Generation Alpha’s influence is taking hold at retail
WSL Strategic Retail has long advised that to see the future of retail, you have to follow the shopper. And today, many of those shoppers are following someone in very small shoes.
Opinion
Retail shrink: We’ve seen the enemy, and it’s us
Retail shrinkage is a challenging topic for me to write about, not just because anytime I see or hear the word shrinkage, I can’t help but think about the Seinfeld episode focused on poor George, a cold swimming pool and an ill-timed “exposure” to a fellow house guest.
Upcoming months may shape pharmacy’s future
The balance of this year and the first months of 2024 will be a time of testing and potential transformation for retail pharmacy. Several pivotal questions, some of which have plagued the industry for many years, seem to be headed toward resolution.
It’s time we honor the MVPs of chain drug retailing
To further recognize the 90th anniversary of the National Association of Chain Drug Stores, it occurs to at least one industry observer that this would be the perfect time to create a Chain Drug Store Hall of Fame.
O-T-C category moving from ‘sick care to ‘well care’
and when I say “us” I do not just mean one company. I
A more intentional approach to vertical integration
In the past few years, “vertical integration” has been a hot topic for leaders in all health care businesses, from pharmacies to insurers to hospitals.
Ways in which the industry can deliver greater value
Value is about how much something is worth, in terms of either cash or importance. In our industry there are a number of different ways to think about value: from the consumer’s eyes; the patient’s eyes; the retailer’s eyes; the brand’s eyes; or the payer’s eyes.
PQA is intent on standardizing pharmacy measures
PQA, the Pharmacy Quality Alliance, launched an initiative in 2019 to develop a standardized set of pharmacy performance measures.
PhRMA: The ‘pill penalty’ imperils cancer drug gains
Earlier this summer, I had a front-row seat for the amazing progress biopharmaceutical companies are making in the battle against cancer. The deluge of data at this year’s American Society for Clinical Oncology (ASCO) meeting provided many reasons to cheer.
Momentum clear at midpoint of NACDS’ 90th year
More than six months into NACDS’ 90th Anniversary Year, the association continues to leverage a defining moment for pharmacy and for health and wellness.
To reduce health care costs, untether Rx
President Joe Biden earlier this month unveiled a series of measures designed to help rein in high health care costs, which constitute a heavy financial and psychological burden for many Americans.
TSE doesn’t deserve its stepchild status
Perhaps the most underrated and underappreciated retail trade event in America today is the exposition about to unfold in San Diego.
Walmart offers Rx for health care’s ills
Walmart has taken several significant steps to heighten the impact of its pharmacists on the health and well-being of Americans.
Women’s power is thankfully here to stay
Make no mistake: In mass retailing, as in other fields of endeavor, this is truly the Age of the Woman. Forget the stories that name the 10, 20 or even 50 most important women in mass retailing. Women have gone far beyond that. Indeed, they have come to exert an impact on the mass retailing
Government pressure on PBMs mounts
It appears that a day of reckoning for pharmacy benefits managers has arrived.
NACDS continues to adapt to meet changing times
As I reflect back on my attending the NACDS Annual Meeting in April, it is with fond memories and a wonderful look back at an industry that has become a health care provider like no other. The role of pharmacy has changed. Most of us see that and understand what has taken place and will